ExThera Medical was established in 2007 by the Emergence Venture Partners life science incubator and ExThera AB at Karolinska Institute in Stockholm. We focus on the treatment of drug-resistant and drug-sensitive blood infections in high-risk patient populations, and provide field-deployable versions for the biological defense and military fields. Our headquarters is in Martinez, California.
Our European office ExThera Medical Europe B.V. was established in 2018 and is based in Vaals in the Netherlands, centrally located near the border to Germany and Belgium to serve the entire EU.
The company’s first product, Seraph 100 Microbind Affinity Blood Filter, has received CE- certification in 2019, for the reduction of pathogens during bloodstream infection in adjunction to antibiotic therapy, and is commercially available in Europe.